All news

The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, is reporting annual revenue of €11.9 million in FY 2024, representing organic growth of 14% (excluding changes in the scope of consolidation) compared with FY 2023. This acceleration benefited from the successful integration of the Distimp and Spine Innovations acquisitions, which have strengthened the Group’s premium ranges and boosted sales in this segment.

Created in 2004 with 40 founding members (download history), the SFCR has grown steadily over the last decade, with more than 500 active members. More than ever, it is representative of the spinal surgery community in France, both neurosurgical and orthopaedic. The annual conference is a real ‘showcase’ for the society, bringing together around 400 participants in a different city each year, and enabling more than forty manufacturers to exhibit their instruments and present their new technologies in the field of spinal surgery. It will be held 5 to 7 June 2025 at the Centre prouvé in Nancy.

We are delighted to welcome you to Copenhagen for the EUROSPINE 2025 annual meeting. The host city of Copenhagen will welcome you in a dynamic atmosphere, offering a mix of cultural heritage and technological innovation. Copenhagen is known for its emphasis on research and innovation, with numerous universities, research institutes and a thriving technology ecosystem that fosters collaboration and knowledge exchange. This combination of forward-looking science and existing practical knowledge will also be represented in this year's scientific programme. Our conference offers a carefully curated mix of innovative research, practical knowledge and numerous networking opportunities. The synergy between the distinctive charm of Copenhagen and the intellectual rigour of our programme aims to provide a truly enriching experience for all participants. We encourage you to network with your peers, share ideas and take the opportunity to explore the city's vibrant scene between sessions. We hope your time here will inspire and teach you valuable lessons.

We're happy to share with you our new series called "Spine Anatomy Fundamentals"! In this series we will be focusing on basic spine anatomy that everyone should know. Our first lesson explores "The 3 Functions of the Spine".

We're happy to share with you our second episode of our “Spine Anatomy Fundamentals” series! In this episode, we'll be focusing on “the vertebrae”.

The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that it has obtained approvals for its ACIFBOX, VEOS, KAPHORN and TWIN PEAKS ranges in Vietnam. Following this approval, initial orders have been placed, confirming the growing interest in Spineway products in the region.

The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, held a webinar on Thursday, December 5, during which Stéphane Le Roux, CEO of Spineway, reviewed the Group’s latest developments and confirmed its roadmap for the coming years.

The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that the Board of Directors of Spineway (the “Company”) decided at its meeting of December 4, 2024, acting on a delegation of authority granted by the Combined General Meeting of March 25, 2024, under the terms of its twenty-third resolution, to carry out a capital reduction motivated by losses through a reduction in the par value of its shares.

The Spineway Group, a , specialist in innovative implants for the treatment of severe spine disorders, organized a week of training dedicated to medical education from November 4 to 8, 2024. Through practical sessions in the operating room and on anatomical specimens in the laboratory, this intensive program trained over 20 international surgeons in the use of the Group’s ESP cervical and lumbar prostheses. These events also enabled the Group's distributors to provide ongoing training and support for their users.